The argument for an independent US Food and Drug Administration (FDA) has taken on renewed interest following President Trump’s political pressure on the agency to rapidly clear COVID-19 products, most notably a vaccine. But while the idea of a more independent agency enjoys broad stakeholder support, it is far from universal, and practical considerations suggest that the FDA will always face a fair degree of oversight by elected officials.
Still, it remains the hope of many – especially former commissioners who have sat in the political hotseat – that...



![[Test]With 75 Pipeline Candidates, TIL Therapies Gain Momentum in Solid Tumor Space](https://web.insights.norstella-labs.com/resizer/v2/G3M6E2FVDNOJPCEXELJNOIKH64.jpg?smart=true&auth=b5d5c6477bcbd6c122699f47191cbafe560695783f500a6e7b10c4d270965bdc&width=400&height=225)
